Want to see AU:GGR full AI Analyst Report?
Top Page
Reckon Health Care Holdings Ltd
(Sydney:GGR)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.17
▼(-13.50% Downside)
Action:Upgraded
Date:07/05/26
The score is driven primarily by weak financial performance—persistent losses, a very limited revenue base, and ongoing cash burn—partially offset by modest leverage. Technical indicators add downside pressure with the price below key moving averages and negative momentum signals, while valuation is difficult to assess due to negative earnings and no dividend yield data.
Positive Factors
Modest leverage
Sustained low-to-moderate debt reduces near-term refinancing and interest burden risks versus highly levered peers. For a loss-making company this structural cushion preserves optionality and gives management more time to pursue a turnaround or new revenue strategies without immediate solvency pressure.
Negative Factors
Persistent net losses and near-zero revenue
Sustained losses combined with negligible revenue create a structural viability issue: without a clear revenue recovery, the company lacks the top-line base needed for scalable margins, making profitability dependent on either a material business change or continued external funding over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Modest leverage
Sustained low-to-moderate debt reduces near-term refinancing and interest burden risks versus highly levered peers. For a loss-making company this structural cushion preserves optionality and gives management more time to pursue a turnaround or new revenue strategies without immediate solvency pressure.
Read all positive factors
Reckon Health Care Holdings Ltd (GGR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$21.00M
Dividend YieldN/A
Average Volume (3M)5.03K
Price to Earnings (P/E)―
Beta (1Y)0.26
Revenue GrowthN/A
EPS Growth-252.54%
CountryAU
Employees1
SectorGeneral
Sector StrengthN/A
IndustryOther Precious Metals
Share Statistics
EPS (TTM)-0.04
Shares Outstanding140,024,220
10 Day Avg. Volume5,994
30 Day Avg. Volume5,033
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)14.06
Price to Sales (P/S)0.00
P/FCF Ratio-30.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Reckon Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Golden Globe Resources Ltd. (GGR.AX) is an Australian mineral exploration company focused on discovering and developing copper and gold resources. The firm maintains full ownership of the Dooloo Creek Project, which includes two exploration permit...
Reckon Health Care Holdings Ltd Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
20
Very Negative
| Breakdown | TTM | Dec 2024 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.30K | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| Gross Profit | 35.30K | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| EBITDA | -1.10M | 0.00 | 0.00 | -1.20M | -1.20M | -1.40M |
| Net Income | -3.52M | -1.81M | -1.16M | -1.39M | -1.49M | -1.44M |
Balance Sheet | ||||||
| Total Assets | 9.15M | 2.55M | 2.35M | 2.96M | 3.69M | 3.63M |
| Cash, Cash Equivalents and Short-Term Investments | 6.44M | 261.65K | 1.36K | 189.50K | 1.07M | 1.11M |
| Total Debt | 0.00 | 389.86K | 253.00K | 0.00 | 37.50K | 106.50K |
| Total Liabilities | 515.24K | 1.38M | 678.14K | 205.41K | 119.17K | 238.97K |
| Stockholders Equity | 8.63M | 1.18M | 1.67M | 2.75M | 3.57M | 3.39M |
Cash Flow | ||||||
| Free Cash Flow | -2.93M | -546.49K | -479.95K | -1.28M | -1.71M | -2.48M |
| Operating Cash Flow | -2.69M | -482.67K | -373.72K | -1.08M | -1.16M | -1.46M |
| Investing Cash Flow | -557.75K | -47.70K | 110.08K | -329.26K | -557.37K | -1.49M |
| Financing Cash Flow | 12.78M | 790.65K | 75.50K | 530.73K | 1.68M | 3.61M |
Reckon Health Care Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (55)
AU:GGR
Reckon Health Care Holdings Ltd
0.15
-0.04
-21.05%
AU:EIQ
EchoIQ Limited
0.52
0.24
87.27%
Reckon Health Care Holdings Ltd Corporate Events
Golden Globe Resources Confirms Copper-Gold Systems at Dooloo Creek
Jul 29, 2026
Golden Globe Resources reported that Phase 1 diamond drilling at its Dooloo Creek Project in Queensland successfully confirmed copper-gold mineralisation at the Northern Gold and Eastern Breccia prospects. The program validated the company’s...
Golden Globe strikes high-grade copper as drilling advances across Queensland portfolio
Jul 27, 2026
Golden Globe Resources Ltd is an Australia-listed copper and gold explorer focused on large-scale intrusive-related and porphyry-style systems in Queensland and the Lachlan Fold Belt. Its projects include Dooloo Creek, Ridler Creek and Neila Creek...
Golden Globe Resources Launches Phase 2 Drilling at Dooloo Creek Copper-Gold Project
Jun 29, 2026
Golden Globe Resources has begun a Phase 2 drilling program at its Dooloo Creek copper-gold project in Queensland, following strong assays from initial holes at the Eastern Breccia and Northern Gold prospects. The new campaign is designed to probe...
Golden Globe Resources Tightens ASX Compliance in Amended Investor Presentation
Jun 19, 2026
Golden Globe Resources has issued an amended investor presentation, updating disclosures originally released on 11 June 2026 to better align with ASX Listing Rule 5.23 and Clause 9. The changes include adding explicit cross‑references to pri...
Golden Globe drills strong copper-gold hits at Dooloo Creek
May 5, 2026
Golden Globe Resources has reported encouraging assay results from its Phase 1 diamond drilling program at the Dooloo Creek project in Queensland, with significant copper and gold mineralisation intersected at the Northern Gold and Eastern Breccia...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.